KDM1A and prostate carcinoma: In addition to prostate cancer, LSD1 is a key driver in multiple cancers, including Merkel cell carcinoma, acute myeloid leukemia, squamous cell carcinoma, small cell lung cancer, and neuroblastoma (14–17).